Price gouging is unacceptable; anticipatory price gouging is "especially offensive." So say four House Democrats seeking a review of drug company pricing practices.
A Democratic senator wants to know if drug companies are trying to make up for concessions they've promised for health-care reform.
The New York Times reports the drug companies' side:
Drug companies do not deny having raised wholesale prices at the highest rate in years. But they say it has nothing to do with the impending health care legislation. They say the price increases are necessary to maintain profits for research and employment in the face of a difficult business environment, which includes a slowdown in sales of many brand-name products, expiring patents and increasing competition from generic drugs.
What do you think? Should drug companies such as GlaxoSmithKline
